![](https://endpts.com/wp-content/uploads/2024/01/Andy-Scharenberg-Umoja-Biopharma-tile.jpg)
Andy Scharenberg, Umoja Biopharma CEO
AbbVie taps Umoja for new in vivo CAR-T deal
AbbVie penned two deals with Umoja Biopharma for its in vivo CAR-T cell therapy programs, the companies announced Thursday.
AbbVie gets …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.